Stay updated on TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial
Sign up to get notified when there's something new on the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page.

Latest updates to the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a clinical study for the drug TAK-935, which included information on its purpose, methodology, and participant criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference31%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check90 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page.